Sequence variation in PPP1R13L results in a novel form of cardio‐cutaneous syndrome. Issue 3 (9th January 2017)

• Record Type: Journal Article
• Authors: Falik‐Zaccai, Tzipora C; Barsheshet, Yiftah; Mandel, Hanna; Segev, Meital; Lorber, Avraham; Gelberg, Shachaf; Kalfon, Limor; Ben Haroush, Shani; Shalata, Adel; Gelernter‐Yaniv, Liat; Chaim, Sarah; Raviv Shay, Dorith; Khayat, Morad; Werbner, Michal; Levi, Inbar; Shoval, Yishay; Tal, Galit; Shalev, Stavit; Reuveni, Eli; Avitan‐Hersh, Emily; Vlodavsky, Eugene; Appl‐Sarid, Liat; Goldsher, Dorit; Bergman, Reuven; Segal, Zvi; Bitterman‐Deutsch, Ora; Avni, Orly
• Is Part Of: EMBO molecular medicine. Volume 9:Issue 3(2017)
• Page Start: 319
• Page End: 336
• Publication Date: 2017-01-09
• Subjects: dilated cardiomyopathy -- genetics -- inflammation -- myocarditis -- PPP1R13L; Molecular biology -- Periodicals; Medical genetics -- Periodicals; Pathology, Molecular -- Periodicals; 616.04205
• DOI: 10.15252/emmm.201606523
• Languages: English
• ISSNs: 1757-4676

Abstract

Abstract: Dilated cardiomyopathy (DCM) is a life‐threatening disorder whose genetic basis is heterogeneous and mostly unknown. Five Arab Christian infants, aged 4–30 months from four families, were diagnosed with DCM associated with mild skin, teeth, and hair abnormalities. All passed away before age 3. A homozygous sequence variation creating a premature stop codon at PPP1R13L encoding the iASPP protein was identified in three infants and in the mother of the other two. Patients' fibroblasts and PPP1R13L ‐knocked down human fibroblasts presented higher expression levels of pro‐inflammatory cytokine genes in response to lipopolysaccharide, as well as Ppp1r13l ‐knocked down murine cardiomyocytes and hearts of Ppp1r13l ‐deficient mice. The hypersensitivity to lipopolysaccharide was NF‐κB‐dependent, and its inducible binding activity to promoters of pro‐inflammatory cytokine genes was elevated in patients' fibroblasts. RNA sequencing of Ppp1r13l ‐knocked down murine cardiomyocytes and of hearts derived from different stages of DCM development in Ppp1r13l ‐deficient mice revealed the crucial role of iASPP in dampening cardiac inflammatory response. Our results determined PPP1R13L as the gene underlying a novel autosomal‐recessive cardio‐cutaneous syndrome in humans and strongly suggest that the fatal DCM during infancy is a consequence of failure to regulate transcriptional pathways necessary for tuning cardiac threshold response to common inflammatory stressors. Synopsis: A new cardio‐cutaneous syndrome associated with fatal dilated cardiomyopathy is discovered in children with sequence variations in PPP1R13L, which encodes for iASPP. Patient skin‐derived fibroblasts are hypersensitive to inflammatory stimuli, responding with NF‐κB‐dependent high expression levels of pro‐inflammatory cytokines. In a murine model, the affected hearts are associated with pro‐inflammatory transcriptional programs starting early after birth. Further abnormal increase happens with age and in response to inflammatory triggers. Sublethal doses of LPS are fatal in the murine model. Abstract : A new cardio‐cutaneous syndrome associated with fatal dilated cardiomyopathy is discovered in children with sequence variations in PPP1R13L, which encodes for iASPP.